A 35-year-old lactating woman was admitted to the general surgery department with abdominal pain. Blood tests showed no alterations. On abdominal ultrasound, multiple hyperechoic lesions were detected. Contrast-enhanced liver MRI was performed to characterize the lesions. Precontrast in-phase and out-of-phase sequences, T2-weighted images (WI), and pre-and postcontrast fat-suppressed (FS) T1-WI were evaluated. All lesions were isointense on in-phase images, hyperintense on T2-WI, and showed marked signal dropout on FS and out-of-phase sequences (Figure 1 . a-e.). MRI confirmed multiple (10 lesions) fat-containing, slowly enhancing lesions, which were suggestive of liver adenomatosis. All lesions showed intense 18 F-FDG uptake ( Figure 2 ). The biggest lesion was 8 cm, with the standardized uptake value (SUV max ) of 7.6. Ultrasonography guided tru-cut biopsy revealed liver adenomas. Informed consent was obtained from all patients for MRI, PET-CT scans, and biopsy.
Liver adenomatosis is a very rare entity, and PET-avid liver adenomatosis is a very uncommon manifestation. Previous studies have found no correlation between liver adenomatosis and glycogen storage disease, steroid intake, or oral contraceptive use because it occurs in normal liver parenchyma (1,2). It affects both women and men, but some studies have reported female dominancy and oral contraceptive use (3, 4) . Our patient had no history of oral contraceptive use.
To our knowledge, this is the third case of PET-avid adenomatosis. All reported cases are HNF1-α mutated subtype and/or steatotic. There is no defined PET-positive inflammatory or telengiectatic subtype of liver adenomas It is well known that focal fatty infiltrations and fat necrosis can be PET positive. The fatty infiltration of activated Kupffer cells leads to subacute inflammation, causing a higher SUV max than the normal parenchyma (6,7). Thus, PET-CT can predict the HNF1-α subtype, which is the type of liver adenomas with the lowest risk for malignancy and hemorrhage (6) .
Hepatic adenomas demonstrate various imaging findings based on their histologic subtypes and hemorrhagic components (6) . MRI is the primary technique to evaluate the fat content and hemorrhage, which are very rare in metastasis, and is the best technique before biopsy to demonstrate steatotic changes, morphological characterization, and differential diagnosis of liver lesions (5, 8) .
PET-MR scanning could also be taken into consideration for the identification of these lesions because it can determine both 18 F-FDG uptake and lesion characterization.
Informed Consent: Informed consent was obtained from the patients who participated in this study. 
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